Compounding Risks to Patients: Selective Disclosure is Not an Option

Compounding Risks to Patients: Selective Disclosure is Not an Option

Bibliographic Details
Main Author:	McGoey, L
Format:	Journal article
Published:	2009

Similar Items

Truth, Disclosure and the Influence of Industry on the Development of NICE Guidelines: An Interview with Tim Kendall
by: McGoey, L, et al.
Published: (2007)

Strategic unknowns: the usefulness of ambiguity and ignorance in organisational life
by: McGoey, L
Published: (2009)

Sequestered Evidence and the Distortion of Clinical Practice Guidelines
by: McGoey, L
Published: (2009)

Philanthrocapitalism and the Greed of Giving: The Adverse Effects of New Philanthropic Players in Health Funding
by: McGoey, L
Published: (2009)

Pharmaceutical Controversies and the Performative Value of Uncertainty
by: McGoey, L
Published: (2009)

Methodological mimesis and the value of pharmaceutical failures
by: McGoey, L
Published: (2009)

Pharmaceutical Hope
by: McGoey, L
Published: (2007)

The Politics of Personalised Medicine: Pharmacogenetics in the Clinic By Adam Hedgecoe
by: McGoey, L
Published: (2007)

The windfalls after the storm
by: McGoey, L
Published: (2007)

Marx is dead: don't resuscitate him
by: McGoey, L
Published: (2008)

On the will to ignorance in bureaucracy
by: McGoey, L
Published: (2007)

Profitable failure: antidepressant drugs and the triumph of flawed experiments
by: McGoey, L
Published: (2010)

Doing good and doing well
by: McGoey, L
Published: (2008)

Experimental dissidence: economies of credibility in drug regulation
by: McGoey, L
Published: (2010)

Betrayed by their disciples
by: McGoey, L
Published: (2007)

After Markets: Researching Hybrid Arrangements
by: McGoey, L, et al.
Published: (2010)

Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
by: McGoey, L, et al.
Published: (2008)

An Elusive Evidence Base: The Construction and Governance of Randomized Controlled Trials
by: Wahlberg, A, et al.
Published: (2007)

Photography and Folk Art at the Art Institute of Chicago: new models for exhibitions and scholarship
by: Elizabeth McGoey, et al.
Published: (2022-06-01)

If NICE was in the USA
by: Kendall, T, et al.
Published: (2009)

Water availability as an agent of selection in introduced populations of Arabidopsis thaliana: impacts on flowering time evolution
by: Amanda J. Stock, et al.
Published: (2015-04-01)

Disclosure versus measurement : investors' reaction to stock options compensation.
by: Mok, Heng Wah., et al.
Published: (2008)

Assessing the Impact of Credit Risk on Equity Options via Information Contents and Compound Options
by: Federico Maglione, et al.
Published: (2023-10-01)

Employee stock options schemes in Singapore : pricing and accounting issues and disclosures.
by: Lee, Mike Chiang Hai., et al.
Published: (2009)

Optional data disclosure and the online privacy paradox: a UK perspective
by: Williams, M, et al.
Published: (2016)

Value relevance of stock option compensation disclosures of NASDAQ100 companies.
by: Choo, Boo Geok.
Published: (2008)

Management disclosure of risk factors and COVID-19
by: Tim Loughran, et al.
Published: (2023-02-01)

The value relevance of risk-related disclosure: Does the tone of disclosure matter?
by: Tamer Elshandidy, et al.
Published: (2022-05-01)

Identifying the Challenges of “Small” Pathology Residency Programs and Creating Collaborative Solutions
by: Robin McGoey MS, MD, et al.
Published: (2016-04-01)

Crash risk and ESG disclosure
by: Paulo Pereira da Silva
Published: (2022-07-01)

Risk Management Committee and Textual Risk Disclosure
by: Eka Sari Ayuningtyas, et al.
Published: (2022-02-01)

ESG Risk Disclosure and the Risk of Green Washing
by: Chitra S De Silva Lokuwaduge, et al.
Published: (2022-02-01)

Artificial intelligence in medicine and the disclosure of risks
by: Kiener, MAH
Published: (2020)

Risk disclosure and corporate governance characteristics
by: Ag Kaifah Riyard Kiflee, et al.
Published: (2020)

Risk Information in Non-Financial Disclosure
by: Justyna Fijałkowska, et al.
Published: (2022-01-01)

Providing Data With High Utility And No Disclosure Risk For The Public and Researchers: An Evaluation By Advanced Statistical Disclosure Risk Methods
by: Matthias Templ
Published: (2014-06-01)

Patient Perception of Physician Attire Before and After Disclosure of the Risks of Microbial Contamination
by: Enoch C. T. So, et al.
Published: (2013-12-01)

Patient Perception of Physician Attire Before and After Disclosure of the Risks of Microbial Contamination
by: Enoch C. T. So, et al.
Published: (2013-12-01)

Discretionary risks disclosure: a management perspective
by: Roshayani Arshad,, et al.
Published: (2011)

Risk management committee and financial instrument disclosure
by: Mohamat Sabri Hassan,, et al.
Published: (2012)